Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 108

The DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.

Large-scale production of human pluripotent stem cell derived cardiomyocytes

Kempf, Henning, Andree, Birgit, Zweigerdt, Robert·2016·Advanced Drug Delivery Reviews

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.addr.2015.11.016

Cites

17 of 17 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 17 references

Research works printed but not linked: 139

  1. Zweigerdt, 2007, The art of cobbling a running pump—will human embryonic stem cells mend broken hearts?, Semin. Cell Dev. Biol., 18, 794, 10.1016/j.semcdb.2007.09.014 · DOI
  2. Soonpaa, 2013, Challenges measuring cardiomyocyte renewal, Biochim. Biophys. Acta, 1833, 799, 10.1016/j.bbamcr.2012.10.029 · DOI
  3. van Berlo, 2014, c-kit+cells minimally contribute cardiomyocytes to the heart, Nature, 509, 337, 10.1038/nature13309 · DOI · Paper page
  4. Rojas, 2015, A new era of ventricular assist device surgery: less invasive procedures, Minerva Chir., 70, 63
  5. Murry, 2005, Cell-based cardiac repair: reflections at the 10-year point, Circulation, 112, 3174, 10.1161/CIRCULATIONAHA.105.546218 · DOI · Paper page
  6. Donndorf, 2013, Stem cell therapy for the treatment of acute myocardial infarction and chronic ischemic heart disease, Curr. Pharm. Biotechnol., 14, 12
  7. Parsa, 2016, Bioengineering methods for myocardial regeneration, Adv. Drug Deliv. Rev, 96, 195, 10.1016/j.addr.2015.06.012 · DOI
  8. Masuda, 2016, Three-dimensional cardiac tissue fabrication based on cell sheet technology, Adv. Drug Deliv. Rev, 96, 103, 10.1016/j.addr.2015.05.002 · DOI
  9. Liaw, 2016, Mechanical stimulation in the engineering of heart muscle, Adv. Drug Deliv. Rev, 96, 156, 10.1016/j.addr.2015.09.001 · DOI
  10. Templin, 2012, Circulation, 126, 430, 10.1161/CIRCULATIONAHA.111.087684 · DOI · Paper page
  11. Ye, 2014, Cardiac repair in a porcine model of acute myocardial infarction with human induced pluripotent stem cell-derived cardiovascular cells, Cell Stem Cell, 15, 750, 10.1016/j.stem.2014.11.009 · DOI · Paper page
  12. Lian, 2014, Efficient differentiation of human pluripotent stem cells to endothelial progenitors via small-molecule activation of WNT signaling, Stem Cell Rep., 3, 804, 10.1016/j.stemcr.2014.09.005 · DOI · Paper page
  13. Dar, 2012, Multipotent vasculogenic pericytes from human pluripotent stem cells promote recovery of murine ischemic limb, Circulation, 125, 87, 10.1161/CIRCULATIONAHA.111.048264 · DOI · Paper page
  14. Patsch, 2015, Generation of vascular endothelial and smooth muscle cells from human pluripotent stem cells, Nat. Cell Biol., 17, 994, 10.1038/ncb3205 · DOI · Paper page
  15. Chen, 2011, Enabling a robust scalable manufacturing process for therapeutic exosomes through oncogenic immortalization of human ESC-derived MSCs, J. Transl. Med., 9, 47, 10.1186/1479-5876-9-47 · DOI · Paper page
  16. Kempf, 2014, Controlling expansion and cardiomyogenic differentiation of human pluripotent stem cells in scalable suspension culture, Stem Cell Rep., 3, 1132, 10.1016/j.stemcr.2014.09.017 · DOI · Paper page
  17. Zweigerdt, 2009, Large scale production of stem cells and their derivatives, Adv. Biochem. Eng. Biotechnol., 114, 201
  18. Takahashi, 2006, Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors, Cell, 126, 663, 10.1016/j.cell.2006.07.024 · DOI · Paper page
  19. Takahashi, 2007, Induction of pluripotent stem cells from adult human fibroblasts by defined factors, Cell, 131, 861, 10.1016/j.cell.2007.11.019 · DOI · Paper page
  20. Yu, 2007, Induced pluripotent stem cell lines derived from human somatic cells, Science, 318, 1917, 10.1126/science.1151526 · DOI · Paper page
  21. Tanaka, 2015, Cardiovascular disease modeling using patient-specific induced pluripotent stem cells, Int. J. Mol. Sci., 16, 18894, 10.3390/ijms160818894 · DOI
  22. Fatima, 2013, The disease-specific phenotype in cardiomyocytes derived from induced pluripotent stem cells of two long QT syndrome type 3 patients, PLoS One, 8, e83005, 10.1371/journal.pone.0083005 · DOI
  23. Schwartz, 2012, Embryonic stem cell trials for macular degeneration: a preliminary report, Lancet, 379, 713, 10.1016/S0140-6736(12)60028-2 · DOI · Paper page
  24. Menasche, 2015, Towards a clinical use of human embryonic stem cell-derived cardiac progenitors: a translational experience, Eur. Heart J., 36, 743, 10.1093/eurheartj/ehu192 · DOI · Paper page
  25. Okita, 2011, Immunogenicity of induced pluripotent stem cells, Circ. Res., 109, 720, 10.1161/RES.0b013e318232e187 · DOI
  26. Zhao, 2011, Immunogenicity of induced pluripotent stem cells, Nature, 474, 212, 10.1038/nature10135 · DOI · Paper page
  27. Araki, 2013, Negligible immunogenicity of terminally differentiated cells derived from induced pluripotent or embryonic stem cells, Nature, 494, 100, 10.1038/nature11807 · DOI · Paper page
  28. de Almeida, 2014, Transplanted terminally differentiated induced pluripotent stem cells are accepted by immune mechanisms similar to self-tolerance, Nat. Commun., 5, 3903, 10.1038/ncomms4903 · DOI · Paper page
  29. Zhao, 2015, Humanized mice reveal differential immunogenicity of cells derived from autologous induced pluripotent stem cells, Cell Stem Cell, 17, 353, 10.1016/j.stem.2015.07.021 · DOI · Paper page
  30. Reardon, 2014, Japan stem-cell trial stirs envy, Nature, 513, 287, 10.1038/513287a · DOI
  31. Jenkins, 2015, Human pluripotent stem cell-derived products: advances towards robust, scalable and cost-effective manufacturing strategies, Biotechnol. J., 10, 83, 10.1002/biot.201400348 · DOI · Paper page
  32. Zimmermann, 2012, Haplotype-based banking of human pluripotent stem cells for transplantation: potential and limitations, Stem Cells Dev., 21, 2364, 10.1089/scd.2012.0088 · DOI
  33. Haase, 2009, Generation of induced pluripotent stem cells from human cord blood, Cell Stem Cell, 5, 434, 10.1016/j.stem.2009.08.021 · DOI · Paper page
  34. Chen, 2015, Development of a scalable suspension culture for cardiac differentiation from human pluripotent stem cells, Stem Cell Res., 15, 365, 10.1016/j.scr.2015.08.002 · DOI · Paper page
  35. Chu, 2001, Industrial choices for protein production by large-scale cell culture, Curr. Opin. Biotechnol., 12, 180, 10.1016/S0958-1669(00)00197-X · DOI · Paper page
  36. Mummery, 2012, Differentiation of human embryonic stem cells and induced pluripotent stem cells to cardiomyocytes: a methods overview, Circ. Res., 111, 344, 10.1161/CIRCRESAHA.110.227512 · DOI · Paper page
  37. Amit, 2010, Suspension culture of undifferentiated human embryonic and induced pluripotent stem cells, Stem Cell Rev., 6, 248, 10.1007/s12015-010-9149-y · DOI
  38. Konze, 2014, Cleavage of E-cadherin and beta-catenin by calpain affects Wnt signaling and spheroid formation in suspension cultures of human pluripotent stem cells, Mol. Cell. Proteomics, 13, 990, 10.1074/mcp.M113.033423 · DOI
  39. Lei, 2013, A fully defined and scalable 3D culture system for human pluripotent stem cell expansion and differentiation, Proc. Natl. Acad. Sci. U. S. A., 110, E5039, 10.1073/pnas.1309408110 · DOI · Paper page
  40. Lou, 2014, The use of nanofibrillar cellulose hydrogel as a flexible three-dimensional model to culture human pluripotent stem cells, Stem Cells Dev., 23, 380, 10.1089/scd.2013.0314 · DOI · Paper page
  41. Celiz, 2014, Materials for stem cell factories of the future, Nat. Mater., 13, 570, 10.1038/nmat3972 · DOI · Paper page
  42. Zweigerdt, 2003, Generation of confluent cardiomyocyte monolayers derived from embryonic stem cells in suspension: a cell source for new therapies and screening strategies, Cytotherapy, 5, 399, 10.1080/14653240310003062 · DOI
  43. Zweigerdt, 2011, Scalable expansion of human pluripotent stem cells in suspension culture, Nat. Protoc., 6, 689, 10.1038/nprot.2011.318 · DOI · Paper page
  44. Otsuji, 2014, A 3D sphere culture system containing functional polymers for large-scale human pluripotent stem cell production, Stem Cell Rep., 2, 734, 10.1016/j.stemcr.2014.03.012 · DOI
  45. Olmer, 2012, Suspension culture of human pluripotent stem cells in controlled, stirred bioreactors, Tissue Eng. Part C Methods, 18, 772, 10.1089/ten.tec.2011.0717 · DOI · Paper page
  46. dos Santos, 2013, Bioreactor design for clinical-grade expansion of stem cells, Biotechnol. J., 8, 644, 10.1002/biot.201200373 · DOI
  47. Ilin, 2015, Secondary ion mass spectrometry and Raman spectroscopy for tissue engineering applications, Curr. Opin. Biotechnol., 31, 108, 10.1016/j.copbio.2014.10.011 · DOI
  48. Lorbeer, 2011, Highly efficient 3D fluorescence microscopy with a scanning laser optical tomograph, Opt. Express, 19, 5419, 10.1364/OE.19.005419 · DOI
  49. Fong, 2005, Perfusion cultures of human embryonic stem cells, Bioprocess Biosyst. Eng., 27, 381, 10.1007/s00449-005-0421-5 · DOI
  50. Serra, 2010, Improving expansion of pluripotent human embryonic stem cells in perfused bioreactors through oxygen control, J. Biotechnol., 148, 208, 10.1016/j.jbiotec.2010.06.015 · DOI
  51. Phillips, 2008, Efficient expansion of clinical-grade human fibroblasts on microcarriers: cells suitable for ex vivo expansion of clinical-grade hESCs, J. Biotechnol., 134, 79, 10.1016/j.jbiotec.2007.12.007 · DOI
  52. Oh, 2009, Long-term microcarrier suspension cultures of human embryonic stem cells, Stem Cell Res., 2, 219, 10.1016/j.scr.2009.02.005 · DOI · Paper page
  53. Kleger, 2010, Modulation of calcium-activated potassium channels induces cardiogenesis of pluripotent stem cells and enrichment of pacemaker-like cells, Circulation, 122, 1823, 10.1161/CIRCULATIONAHA.110.971721 · DOI
  54. Silva, 2015, Robust expansion of human pluripotent stem cells: integration of bioprocess design with transcriptomic and metabolomic characterization, Stem Cells Transl. Med., 4, 731, 10.5966/sctm.2014-0270 · DOI
  55. Polykandriotis, 2008, To matrigel or not to matrigel, Am. J. Pathol., 172, 1441, 10.2353/ajpath.2008.071215 · DOI
  56. Ellerstrom, 2007, Facilitated expansion of human embryonic stem cells by single-cell enzymatic dissociation, Stem Cells, 25, 1690, 10.1634/stemcells.2006-0607 · DOI
  57. Amit, 2011, Dynamic suspension culture for scalable expansion of undifferentiated human pluripotent stem cells, Nat. Protoc., 6, 572, 10.1038/nprot.2011.325 · DOI
  58. Olmer, 2010, Long term expansion of undifferentiated human iPS and ES cells in suspension culture using a defined medium, Stem Cell Res., 5, 51, 10.1016/j.scr.2010.03.005 · DOI · Paper page
  59. Singh, 2010, Up-scaling single cell-inoculated suspension culture of human embryonic stem cells, Stem Cell Res., 4, 165, 10.1016/j.scr.2010.03.001 · DOI · Paper page
  60. Wang, 2007, Self-renewal of human embryonic stem cells requires insulin-like growth factor-1 receptor and ERBB2 receptor signaling, Blood, 110, 4111, 10.1182/blood-2007-03-082586 · DOI · Paper page
  61. Chen, 2012, Scalable GMP compliant suspension culture system for human ES cells, Stem Cell Res., 8, 388, 10.1016/j.scr.2012.02.001 · DOI
  62. Wang, 2013, Scalable expansion of human induced pluripotent stem cells in the defined xeno-free E8 medium under adherent and suspension culture conditions, Stem Cell Res., 11, 1103, 10.1016/j.scr.2013.07.011 · DOI
  63. Hunt, 2014, Factorial experimental design for the culture of human embryonic stem cells as aggregates in stirred suspension bioreactors reveals the potential for interaction effects between bioprocess parameters, Tissue Eng. Part C Methods, 20, 76, 10.1089/ten.tec.2013.0040 · DOI
  64. Abbasalizadeh, 2012, Bioprocess development for mass production of size-controlled human pluripotent stem cell aggregates in stirred suspension bioreactor, Tissue Eng. Part C Methods, 18, 831, 10.1089/ten.tec.2012.0161 · DOI
  65. Kehat, 2001, Human embryonic stem cells can differentiate into myocytes with structural and functional properties of cardiomyocytes, J. Clin. Invest., 108, 407, 10.1172/JCI200112131 · DOI
  66. Mummery, 2003, Differentiation of human embryonic stem cells to cardiomyocytes: role of coculture with visceral endoderm-like cells, Circulation, 107, 2733, 10.1161/01.CIR.0000068356.38592.68 · DOI · Paper page
  67. Burridge, 2012, Production of de novo cardiomyocytes: human pluripotent stem cell differentiation and direct reprogramming, Cell Stem Cell, 10, 16, 10.1016/j.stem.2011.12.013 · DOI · Paper page
  68. Laflamme, 2007, Cardiomyocytes derived from human embryonic stem cells in pro-survival factors enhance function of infarcted rat hearts, Nat. Biotechnol., 25, 1015, 10.1038/nbt1327 · DOI · Paper page
  69. Burridge, 2011, A universal system for highly efficient cardiac differentiation of human induced pluripotent stem cells that eliminates interline variability, PLoS One, 6, e18293, 10.1371/journal.pone.0018293 · DOI · Paper page
  70. Elliott, 2011, NKX2-5(eGFP/w) hESCs for isolation of human cardiac progenitors and cardiomyocytes, Nat. Methods, 8, 1037, 10.1038/nmeth.1740 · DOI · Paper page
  71. Kawamura, 2012, Feasibility, safety, and therapeutic efficacy of human induced pluripotent stem cell-derived cardiomyocyte sheets in a porcine ischemic cardiomyopathy model, Circulation, 126, S29, 10.1161/CIRCULATIONAHA.111.084343 · DOI · Paper page
  72. Freund, 2008, Insulin redirects differentiation from cardiogenic mesoderm and endoderm to neuroectoderm in differentiating human embryonic stem cells, Stem Cells, 26, 724, 10.1634/stemcells.2007-0617 · DOI
  73. Xu, 2008, Chemically defined medium supporting cardiomyocyte differentiation of human embryonic stem cells, Differentiation, 76, 958, 10.1111/j.1432-0436.2008.00284.x · DOI · Paper page
  74. Passier, 2005, Increased cardiomyocyte differentiation from human embryonic stem cells in serum-free cultures, Stem Cells, 23, 772, 10.1634/stemcells.2004-0184 · DOI · Paper page
  75. Graichen, 2008, Enhanced cardiomyogenesis of human embryonic stem cells by a small molecular inhibitor of p38 MAPK, Differentiation, 76, 357, 10.1111/j.1432-0436.2007.00236.x · DOI · Paper page
  76. Gaur, 2010, Timed inhibition of p38MAPK directs accelerated differentiation of human embryonic stem cells into cardiomyocytes, Cytotherapy, 12, 807, 10.3109/14653249.2010.491821 · DOI
  77. Kempf, 2011, Distinct regulation of mitogen-activated protein kinase activities is coupled with enhanced cardiac differentiation of human embryonic stem cells, Stem Cell Res., 7, 198, 10.1016/j.scr.2011.06.001 · DOI
  78. Ueno, 2007, Biphasic role for Wnt/beta-catenin signaling in cardiac specification in zebrafish and embryonic stem cells, Proc. Natl. Acad. Sci. U. S. A., 104, 9685, 10.1073/pnas.0702859104 · DOI · Paper page
  79. Ren, 2011, Small molecule Wnt inhibitors enhance the efficiency of BMP-4-directed cardiac differentiation of human pluripotent stem cells, J. Mol. Cell. Cardiol., 51, 280, 10.1016/j.yjmcc.2011.04.012 · DOI
  80. Willems, 2011, Small-molecule inhibitors of the Wnt pathway potently promote cardiomyocytes from human embryonic stem cell-derived mesoderm, Circ. Res., 109, 360, 10.1161/CIRCRESAHA.111.249540 · DOI · Paper page
  81. Hudson, 2012, Primitive cardiac cells from human embryonic stem cells, Stem Cells Dev., 21, 1513, 10.1089/scd.2011.0254 · DOI
  82. Minami, 2012, A small molecule that promotes cardiac differentiation of human pluripotent stem cells under defined, cytokine- and xeno-free conditions, Cell Rep., 2, 1448, 10.1016/j.celrep.2012.09.015 · DOI · Paper page
  83. Gonzalez, 2011, Stepwise chemically induced cardiomyocyte specification of human embryonic stem cells, Angew. Chem., 50, 11181, 10.1002/anie.201103909 · DOI
  84. David, 2008, MesP1 drives vertebrate cardiovascular differentiation through Dkk-1-mediated blockade of Wnt-signalling, Nat. Cell Biol., 10, 338, 10.1038/ncb1696 · DOI · Paper page
  85. Lian, 2013, Directed cardiomyocyte differentiation from human pluripotent stem cells by modulating Wnt/beta-catenin signaling under fully defined conditions, Nat. Protoc., 8, 162, 10.1038/nprot.2012.150 · DOI · Paper page
  86. Thomson, 1998, Embryonic stem cell lines derived from human blastocysts, Science, 282, 1145, 10.1126/science.282.5391.1145 · DOI · Paper page
  87. Ting, 2014, Time-resolved video analysis and management system for monitoring cardiomyocyte differentiation processes and toxicology assays, Biotechnol. J., 9, 675, 10.1002/biot.201300262 · DOI
  88. Rust, 2009, Cardiomyocyte enrichment from human embryonic stem cell cultures by selection of ALCAM surface expression, Regen. Med., 4, 225, 10.2217/17460751.4.2.225 · DOI
  89. Van Hoof, 2010, Identification of cell surface proteins for antibody-based selection of human embryonic stem cell-derived cardiomyocytes, J. Proteome Res., 9, 1610, 10.1021/pr901138a · DOI
  90. Dubois, 2011, SIRPA is a specific cell-surface marker for isolating cardiomyocytes derived from human pluripotent stem cells, Nat. Biotechnol., 29, 1011, 10.1038/nbt.2005 · DOI · Paper page
  91. Uosaki, 2011, Efficient and scalable purification of cardiomyocytes from human embryonic and induced pluripotent stem cells by VCAM1 surface expression, PLoS One, 6, e23657, 10.1371/journal.pone.0023657 · DOI · Paper page
  92. Davis, 2008, Targeting a GFP reporter gene to the MIXL1 locus of human embryonic stem cells identifies human primitive streak-like cells and enables isolation of primitive hematopoietic precursors, Blood, 111, 1876, 10.1182/blood-2007-06-093609 · DOI · Paper page
  93. Fujiwara, 2011, Induction and enhancement of cardiac cell differentiation from mouse and human induced pluripotent stem cells with cyclosporin-A, PLoS One, 6, e16734, 10.1371/journal.pone.0016734 · DOI
  94. Blin, 2010, A purified population of multipotent cardiovascular progenitors derived from primate pluripotent stem cells engrafts in postmyocardial infarcted nonhuman primates, J. Clin. Invest., 120, 1125, 10.1172/JCI40120 · DOI · Paper page
  95. Leschik, 2008, Cardiac commitment of primate embryonic stem cells, Nat. Protoc., 3, 1381, 10.1038/nprot.2008.116 · DOI
  96. Evseenko, 2010, Mapping the first stages of mesoderm commitment during differentiation of human embryonic stem cells, Proc. Natl. Acad. Sci. U. S. A., 107, 13742, 10.1073/pnas.1002077107 · DOI · Paper page
  97. Ardehali, 2013, Prospective isolation of human embryonic stem cell-derived cardiovascular progenitors that integrate into human fetal heart tissue, Proc. Natl. Acad. Sci. U. S. A., 110, 3405, 10.1073/pnas.1220832110 · DOI
  98. Den Hartogh, 2015, Dual reporter MESP1–NKX2-5 hESCs enable studying early human cardiac differentiation, Stem Cells, 33, 56, 10.1002/stem.1842 · DOI
  99. Bu, 2009, Human ISL1 heart progenitors generate diverse multipotent cardiovascular cell lineages, Nature, 460, 113, 10.1038/nature08191 · DOI · Paper page
  100. Ritner, 2011, An engineered cardiac reporter cell line identifies human embryonic stem cell-derived myocardial precursors, PLoS One, 6, e16004, 10.1371/journal.pone.0016004 · DOI
  101. Huber, 2007, Identification and selection of cardiomyocytes during human embryonic stem cell differentiation, FASEB J., 21, 2551, 10.1096/fj.05-5711com · DOI · Paper page
  102. Ovchinnikov, 2015, Isolation of contractile cardiomyocytes from human pluripotent stem-cell-derived cardiomyogenic cultures using a human NCX1-EGFP reporter, Stem Cells Dev., 24, 11, 10.1089/scd.2014.0195 · DOI
  103. Lock, 2009, Expansion and differentiation of human embryonic stem cells to endoderm progeny in a microcarrier stirred-suspension culture, Tissue Eng. A, 15, 2051, 10.1089/ten.tea.2008.0455 · DOI · Paper page
  104. Vosough, 2013, Generation of functional hepatocyte-like cells from human pluripotent stem cells in a scalable suspension culture, Stem Cells Dev., 22, 2693, 10.1089/scd.2013.0088 · DOI
  105. Niebruegge, 2009, Generation of human embryonic stem cell-derived mesoderm and cardiac cells using size-specified aggregates in an oxygen-controlled bioreactor, Biotechnol. Bioeng., 102, 493, 10.1002/bit.22065 · DOI · Paper page
  106. Haraguchi, 2013, Simple suspension culture system of human iPS cells maintaining their pluripotency for cardiac cell sheet engineering, J. Tissue Eng. Regen. Med.
  107. Lecina, 2010, Scalable platform for human embryonic stem cell differentiation to cardiomyocytes in suspended microcarrier cultures, Tissue Eng. Part C Methods, 16, 1609, 10.1089/ten.tec.2010.0104 · DOI
  108. Ting, 2014, An intermittent rocking platform for integrated expansion and differentiation of human pluripotent stem cells to cardiomyocytes in suspended microcarrier cultures, Stem Cell Res., 13, 202, 10.1016/j.scr.2014.06.002 · DOI
  109. Kempf, 2015, Cardiac differentiation of human pluripotent stem cells in scalable suspension culture, Nat. Protoc., 10, 1345, 10.1038/nprot.2015.089 · DOI · Paper page
  110. Chong, 2014, Human embryonic-stem-cell-derived cardiomyocytes regenerate non-human primate hearts, Nature, 510, 273, 10.1038/nature13233 · DOI · Paper page
  111. Schroeder, 2005, Differentiation and lineage selection of mouse embryonic stem cells in a stirred bench scale bioreactor with automated process control, Biotechnol. Bioeng., 92, 920, 10.1002/bit.20668 · DOI · Paper page
  112. Niebruegge, 2008, Cardiomyocyte production in mass suspension culture: embryonic stem cells as a source for great amounts of functional cardiomyocytes, Tissue Eng. A, 14, 1591, 10.1089/ten.tea.2007.0247 · DOI
  113. Fridley, 2012, Hydrodynamic modulation of pluripotent stem cells, Stem Cell Res. Ther., 3, 45, 10.1186/scrt136 · DOI
  114. Burridge, 2007, Improved human embryonic stem cell embryoid body homogeneity and cardiomyocyte differentiation from a novel V-96 plate aggregation system highlights interline variability, Stem Cells, 25, 929, 10.1634/stemcells.2006-0598 · DOI · Paper page
  115. Mohr, 2010, The microwell control of embryoid body size in order to regulate cardiac differentiation of human embryonic stem cells, Biomaterials, 31, 1885, 10.1016/j.biomaterials.2009.11.033 · DOI · Paper page
  116. Dahlmann, 2013, The use of agarose microwells for scalable embryoid body formation and cardiac differentiation of human and murine pluripotent stem cells, Biomaterials, 34, 2463, 10.1016/j.biomaterials.2012.12.024 · DOI
  117. Hentze, 2009, Teratoma formation by human embryonic stem cells: evaluation of essential parameters for future safety studies, Stem Cell Res., 2, 198, 10.1016/j.scr.2009.02.002 · DOI · Paper page
  118. Hattori, 2010, Nongenetic method for purifying stem cell-derived cardiomyocytes, Nat. Methods, 7, 61, 10.1038/nmeth.1403 · DOI · Paper page
  119. Ban, 2013, Purification of cardiomyocytes from differentiating pluripotent stem cells using molecular beacons that target cardiomyocyte-specific mRNA, Circulation, 128, 1897, 10.1161/CIRCULATIONAHA.113.004228 · DOI
  120. Miki, 2015, Efficient detection and purification of cell populations using synthetic microRNA switches, Cell Stem Cell, 16, 699, 10.1016/j.stem.2015.04.005 · DOI · Paper page
  121. Tohyama, 2013, Distinct metabolic flow enables large-scale purification of mouse and human pluripotent stem cell-derived cardiomyocytes, Cell Stem Cell, 12, 127, 10.1016/j.stem.2012.09.013 · DOI · Paper page
  122. Fuerstenau-Sharp, 2015, Generation of highly purified human cardiomyocytes from peripheral blood mononuclear cell-derived induced pluripotent stem cells, PLoS One, 10, e0126596, 10.1371/journal.pone.0126596 · DOI
  123. Schwanke, 2014, Fast and efficient multitransgenic modification of human pluripotent stem cells, Hum. Gene Ther. Methods, 25, 136, 10.1089/hgtb.2012.248 · DOI
  124. Merkert, 2014, Efficient designer nuclease-based homologous recombination enables direct PCR screening for footprintless targeted human pluripotent stem cells, Stem Cell Rep., 2, 107, 10.1016/j.stemcr.2013.12.003 · DOI
  125. Klug, 1996, Genetically selected cardiomyocytes from differentiating embryonic stem cells form stable intracardiac grafts, J. Clin. Invest., 98, 216, 10.1172/JCI118769 · DOI · Paper page
  126. Anderson, 2007, Transgenic enrichment of cardiomyocytes from human embryonic stem cells, Mol. Ther., 15, 2027, 10.1038/sj.mt.6300303 · DOI · Paper page
  127. Xu, 2008, Highly enriched cardiomyocytes from human embryonic stem cells, Cytotherapy, 10, 376, 10.1080/14653240802105307 · DOI
  128. Martin, 2015, New muscle for old hearts: engineering tissue from pluripotent stem cells, Hum. Gene Ther., 26, 305, 10.1089/hum.2015.022 · DOI
  129. Xu, 2009, Global expression profile of highly enriched cardiomyocytes derived from human embryonic stem cells, Stem Cells, 27, 2163, 10.1002/stem.166 · DOI · Paper page
  130. Sartiani, 2007, Developmental changes in cardiomyocytes differentiated from human embryonic stem cells: a molecular and electrophysiological approach, Stem Cells, 25, 1136, 10.1634/stemcells.2006-0466 · DOI · Paper page
  131. Yang, 2014, Tri-iodo-l-thyronine promotes the maturation of human cardiomyocytes-derived from induced pluripotent stem cells, J. Mol. Cell. Cardiol., 72, 296, 10.1016/j.yjmcc.2014.04.005 · DOI · Paper page
  132. Feric, 2016, Tri-iodo-l-thyronine promotes the maturation of human cardiomyocytes-derived from induced pluripotent stem cells, Adv. Drug Deliv. Rev, 96, 110, 10.1016/j.addr.2015.04.019 · DOI · Paper page
  133. Stoppel, 2016, Electrical and mechanical stimulation of cardiac cells and tissue constructs, Adv. Drug Deliv. Rev, 96, 135, 10.1016/j.addr.2015.07.009 · DOI · Paper page
  134. Kraushaar, 2012, Cardiac safety pharmacology: from human ether-a-gogo related gene channel block towards induced pluripotent stem cell based disease models, Expert Opin. Drug Saf., 11, 285, 10.1517/14740338.2012.639358 · DOI
  135. Karakikes, 2015, Human induced pluripotent stem cell-derived cardiomyocytes: insights into molecular, cellular, and functional phenotypes, Circ. Res., 117, 80, 10.1161/CIRCRESAHA.117.305365 · DOI · Paper page
  136. Lundy, 2014, Cell-based delivery of dATP via gap junctions enhances cardiac contractility, J. Mol. Cell. Cardiol., 72, 350, 10.1016/j.yjmcc.2014.04.010 · DOI
  137. Sekine, 2014, Oxygen consumption of human heart cells in monolayer culture, Biochem. Biophys. Res. Commun., 452, 834, 10.1016/j.bbrc.2014.09.018 · DOI
  138. Mauritz, 2011, Induced pluripotent stem cell (iPSC)-derived Flk-1 progenitor cells engraft, differentiate, and improve heart function in a mouse model of acute myocardial infarction, Eur. Heart J., 32, 2634, 10.1093/eurheartj/ehr166 · DOI
  139. Birket, 2015, Expansion and patterning of cardiovascular progenitors derived from human pluripotent stem cells, Nat. Biotechnol., 33, 970, 10.1038/nbt.3271 · DOI · Paper page

Cited by

See all 108

Metadata

Authors
Kempf, H., Andree, B., & Zweigerdt, R.
Venue
Advanced Drug Delivery Reviews
Publisher
Elsevier BV
Published
2016-01
Volume
96
Pages
18-30
ISSN
0169-409X
Cited by
108
References
17
Language
en
Licence
www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Funders
  • German Research Foundation (DFG EXC62/3, ZW 64/4-1)
  • German Ministry for Education and Science (13N12606)
  • Innovative Medicines Initiative Joint Undertaking (115439-2)
  • European Union (FP7/2007-2013)
  • EFPIA

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Large-scale production of human pluripotent stem cell derived cardiomyocytes. https://app.cochat.ai/papers/10.1016/j.addr.2015.11.016
The paper
Kempf, H., Andree, B., & Zweigerdt, R. (2016). Large-scale production of human pluripotent stem cell derived cardiomyocytes. Advanced Drug Delivery Reviews. https://doi.org/10.1016/j.addr.2015.11.016

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.